These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 24176890)
1. Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery. Hao J; Wang X; Bi Y; Teng Y; Wang J; Li F; Li Q; Zhang J; Guo F; Liu J Colloids Surf B Biointerfaces; 2014 Feb; 114():111-20. PubMed ID: 24176890 [TBL] [Abstract][Full Text] [Related]
2. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Seyfoddin A; Al-Kassas R Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312 [TBL] [Abstract][Full Text] [Related]
3. Lipid Nanocarrier: an Efficient Approach Towards Ocular Delivery of Hydrophilic Drug (Valacyclovir). Kumar R; Sinha VR AAPS PharmSciTech; 2017 Apr; 18(3):884-894. PubMed ID: 27368921 [TBL] [Abstract][Full Text] [Related]
4. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034 [TBL] [Abstract][Full Text] [Related]
5. Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor. Sharma AK; Sahoo PK; Majumdar DK; Sharma N; Sharma RK; Kumar A Drug Deliv; 2016 Nov; 23(9):3364-3373. PubMed ID: 27128623 [TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles for ocular drug delivery. Seyfoddin A; Shaw J; Al-Kassas R Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540 [TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system. Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712 [TBL] [Abstract][Full Text] [Related]
8. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity. Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466 [TBL] [Abstract][Full Text] [Related]
9. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization. Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672 [TBL] [Abstract][Full Text] [Related]
10. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery. Mohanty B; Majumdar DK; Mishra SK; Panda AK; Patnaik S Pharm Dev Technol; 2015 Jun; 20(4):458-64. PubMed ID: 24490828 [TBL] [Abstract][Full Text] [Related]
11. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery. Katara R; Majumdar DK Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566 [TBL] [Abstract][Full Text] [Related]
12. Ocular Disposition of ∆ Punyamurthula NS; Adelli GR; Gul W; Repka MA; ElSohly MA; Majumdar S AAPS PharmSciTech; 2017 Aug; 18(6):1936-1945. PubMed ID: 27905004 [TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of coenzyme Q10 loaded solid lipid nanoparticle hydrogel for enhanced dermal delivery. Korkm E; Gokce EH; Ozer O Acta Pharm; 2013 Dec; 63(4):517-29. PubMed ID: 24451076 [TBL] [Abstract][Full Text] [Related]
14. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Balguri SP; Adelli GR; Majumdar S Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755 [TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution. Kang JH; Chon J; Kim YI; Lee HJ; Oh DW; Lee HG; Han CS; Kim DW; Park CW Int J Nanomedicine; 2019; 14():5381-5396. PubMed ID: 31409994 [No Abstract] [Full Text] [Related]
16. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin. Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511 [TBL] [Abstract][Full Text] [Related]
17. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. Attama AA; Müller-Goymann CC Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752 [TBL] [Abstract][Full Text] [Related]
18. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Liu CH; Wu CT; Fang JY Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495 [TBL] [Abstract][Full Text] [Related]
19. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol)co-polymer. Wang W; Deng L; Liu S; Li X; Zhao X; Hu R; Zhang J; Han H; Dong A Acta Biomater; 2012 Nov; 8(11):3963-73. PubMed ID: 22835677 [TBL] [Abstract][Full Text] [Related]
20. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect. Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]